Europe
United Kingdom
Europe
United Kingdom

The 'go to' European specialist pharma company

Setofilm® 8mg

Setofilm - 8 mgOndansetron, Orodispersible Film

 

Adults:

  • Prophylaxis of acute nausea and vomiting induced by moderately emetogenic chemotherapy.
  • Prophylaxis and treatment of delayed nausea and vomiting induced by moderately to highly emetogenic chemotherapy.
  • Prophylaxis and treatment of acute and delayed nausea and vomiting induced by highly emetogenic radiotherapy.
  • Prophylaxis and treatment of post-operative nausea and vomiting (PONV).


Paediatric Population:

  • Management of chemotherapy-induced nausea and vomiting in children aged ≥6 months.
  • Prophylaxis and treatment of post-operative nausea and vomiting (PONV) in children aged ≥4 years.

 

The links below will redirect you to an alternative site not maintained by Norgine Pharmaceuticals Limited

 

View the Patient Information Leaflet                         

View the Summary of Product Characterisitics

 

 

Please consult with your Doctor, or other qualified Healthcare Professional before use.

 

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

 

By reporting side effects you can help provide more information on the safety of this medicine.

 

UK/COR/0814/0097